HIND
Vyome Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.75
−1.41%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.75
From 52W high−71.72%
Volume5799.00
Market cap$12.25M
P/E (TTM)—
P/S (TTM)94.4x
Div yield—
Key dataNov 4, 2026
Open
$1.75
From 52W high
−71.72%
Volume
5799.00
Market cap
$12.25M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.5x
P/E (TTM)
—
RSI (14)
36.9
MomentumView details →
1D Return
−1.41%
YTD Return
−49.27%
Similar companies
Latest newsMore news →
Vyome Holdings appointed Jerry Leonard as Chief Financial Officer, effective September 1, 2026, succeeding Robert Dickey, who resigned as Interim Chief Financial Officer effective August 31, 2026.68d agoVyome Holdings reported Q2 2026 revenue of $58,546, a net loss of $720,000, and a diluted loss per share of $0.10, with cash and cash equivalents of $7.9 million as of the period end.72d ago